Aims and Scope
Expert Opinion on Therapeutic Patents is a monthly peer-reviewed medical journal covering pharmaceutical patent information across all therapy areas. Each review includes an "expert opinion" section, in which authors provide their personal view on the current status and future direction of the research discussed. The journal was established as Current Opinion on Therapeutic Patents in 1991, and changed to the current name in 1994. It is published by Informa. The editor-in-chief is Claudiu T. Supuran (University of Florence).
Key Metrics
11.2
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.001 - 0.005
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
83
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
Q1
Pharmacology
SJR
- Q1 Pharmacology
- Q1 Drug Discovery
- Q1 Medicine (miscellaneous)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.58
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
5 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Topics Covered
- Matrix metalloproteinase
- Galectin-3
- Aurora kinase
- Myeloid cells
- Matrix metalloproteinase inhibitor
- Cancer therapy
- Riociguat
- Wound healing
- Akt inhibitor
- Type 2 diabetes
- Phosphoglycerate dehydrogenase
- Glaucoma
- RNA-dependent RNA polymerase
- Epidermal growth factor receptor
- Anti-inflammatory
- Inhibitory potency
- Soluble Guanylate Cyclase Stimulator
- Mucormycosis
- Phosphatidylinositol 3-kinase Inhibitor
- Clinical trial
Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1991 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Expert Opinion on Therapeutic Patents ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Patented farnesoid X receptor modulators: a review (2019 – present)
- 3 May 24
- Expert Opinion on Therapeutic Patents
-
Full paper
PCSK9 inhibitors: a patent review 2018-2023
- 10 Apr 24
- Expert Opinion on Therapeutic Patents
-
Full paper
Targeting the PI3K/AKT signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023)
- 10 Apr 24
- Expert Opinion on Therapeutic Patents
-
Full paper
Synthetic lethality: targeting SMARCA2 ATPase in SMARCA4-deficient tumors – a review of patent literature from 2019–30 June 2023
- 7 Apr 24
- Expert Opinion on Therapeutic Patents
-
Full paper
Biofilm and bacterial membrane vesicles: recent advances
- 7 Apr 24
- Expert Opinion on Therapeutic Patents
-
Full paper
Targeting the relaxin-3/RXFP3 system: a patent review for the last two decades
- 6 Apr 24
- Expert Opinion on Therapeutic Patents
Scite analysis
Powered by scite_
3.8k articles received 36.6k citations see all
- 340 Supporting
- 35,718 Mentioning
- 18 Contrasting
Editorial notices
- 2 Retractions
- 0 Withdrawals
- 8 Corrections
- 8 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
9%
4 to 6 months
57%
7 to 9 months
26%
Above 9 months
9%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has Expert Opinion on Therapeutic Patents been actively publishing?
Expert Opinion on Therapeutic Patents has been in operation since 1991 till date.
What is the publishing frequency of Expert Opinion on Therapeutic Patents ?
Expert Opinion on Therapeutic Patents published with a Monthly frequency.
How many articles did Expert Opinion on Therapeutic Patents publish last years ?
In 2023, Expert Opinion on Therapeutic Patents published 52 articles.
What is the eISSN & pISSN for Expert Opinion on Therapeutic Patents ?
For Expert Opinion on Therapeutic Patents,eISSN is 1744-7674 and pISSN is1354-3776.
What is Citescore for Expert Opinion on Therapeutic Patents ?
Citescore for Expert Opinion on Therapeutic Patents is 11.2.
What is H index for Expert Opinion on Therapeutic Patents ?
H index for Expert Opinion on Therapeutic Patents is 83.
What is SNIP score for Expert Opinion on Therapeutic Patents ?
SNIP score for Expert Opinion on Therapeutic Patents is 1.58.
What is the SJR for Expert Opinion on Therapeutic Patents ?
SJR for Expert Opinion on Therapeutic Patents is Q1.
Who is the publisher of Expert Opinion on Therapeutic Patents ?
TAYLOR & FRANCIS LTD is the publisher of Expert Opinion on Therapeutic Patents.